KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $260.68 $288.54 Thursday, 25th Apr 2024 AMGN stock ended at $269.38. This is 1.33% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 2.66% from a day low at $267.24 to a day high of $274.35.
90 days $260.68 $329.72
52 weeks $211.73 $329.72

Historical Amgen Inc. prices

Date Open High Low Close Volume
Aug 15, 2023 $261.32 $266.63 $259.96 $266.01 2 720 658
Aug 14, 2023 $262.22 $263.47 $259.85 $260.97 1 785 640
Aug 11, 2023 $261.70 $264.11 $260.83 $262.51 1 525 912
Aug 10, 2023 $261.54 $264.78 $260.46 $262.06 1 914 468
Aug 09, 2023 $259.92 $263.74 $259.12 $259.32 2 395 778
Aug 08, 2023 $257.52 $263.79 $256.50 $260.80 5 226 947
Aug 07, 2023 $244.25 $253.82 $243.46 $252.94 3 989 932
Aug 04, 2023 $237.91 $246.42 $237.06 $243.28 4 932 144
Aug 03, 2023 $230.79 $231.10 $228.21 $230.70 2 196 716
Aug 02, 2023 $232.72 $233.03 $228.70 $230.41 2 550 177
Aug 01, 2023 $234.93 $235.38 $230.59 $232.12 1 653 418
Jul 31, 2023 $236.48 $236.48 $233.02 $234.15 2 492 001
Jul 28, 2023 $236.82 $238.18 $235.09 $236.37 1 707 649
Jul 27, 2023 $234.48 $238.48 $234.31 $236.05 2 320 386
Jul 26, 2023 $234.36 $235.74 $232.44 $235.21 1 467 060
Jul 25, 2023 $234.36 $236.57 $234.28 $235.31 1 256 170
Jul 24, 2023 $235.00 $236.13 $233.92 $235.42 1 657 396
Jul 21, 2023 $233.77 $236.33 $232.78 $234.82 5 880 983
Jul 20, 2023 $233.81 $238.48 $232.91 $233.23 3 699 585
Jul 19, 2023 $232.98 $234.55 $231.99 $232.05 1 968 192
Jul 18, 2023 $227.79 $234.07 $227.40 $232.57 2 467 533
Jul 17, 2023 $226.87 $228.60 $224.34 $227.84 2 032 710
Jul 14, 2023 $227.84 $228.66 $225.98 $227.43 2 041 997
Jul 13, 2023 $225.85 $228.12 $225.00 $227.66 1 705 988
Jul 12, 2023 $225.17 $227.32 $224.09 $225.68 2 587 444
Click to get the best stock tips daily for free!

About Amgen Inc.

Amgen. Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopaus... AMGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT